Utah Medical Products ROE 2010-2025 | UTMD

Current and historical return on equity (ROE) values for Utah Medical Products (UTMD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Utah Medical Products ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2025-03-31 $0.01B $0.12B 10.79%
2024-12-31 $0.01B $0.12B 11.36%
2024-09-30 $0.02B $0.12B 11.90%
2024-06-30 $0.02B $0.12B 11.90%
2024-03-31 $0.02B $0.13B 12.75%
2023-12-31 $0.02B $0.13B 13.01%
2023-09-30 $0.02B $0.12B 14.23%
2023-06-30 $0.02B $0.12B 14.72%
2023-03-31 $0.02B $0.12B 15.21%
2022-12-31 $0.02B $0.11B 15.53%
2022-09-30 $0.02B $0.11B 14.85%
2022-06-30 $0.02B $0.11B 14.78%
2022-03-31 $0.02B $0.11B 13.86%
2021-12-31 $0.01B $0.11B 13.05%
2021-09-30 $0.01B $0.11B 12.24%
2021-06-30 $0.01B $0.11B 11.62%
2021-03-31 $0.01B $0.11B 9.98%
2020-12-31 $0.01B $0.10B 10.26%
2020-09-30 $0.01B $0.10B 11.34%
2020-06-30 $0.01B $0.10B 12.47%
2020-03-31 $0.02B $0.09B 15.63%
2019-12-31 $0.02B $0.10B 15.71%
2019-09-30 $0.01B $0.10B 15.14%
2019-06-30 $0.02B $0.09B 18.68%
2019-03-31 $0.02B $0.09B 19.26%
2018-12-31 $0.02B $0.09B 20.93%
2018-09-30 $0.01B $0.09B 14.41%
2018-06-30 $0.01B $0.08B 11.08%
2018-03-31 $0.01B $0.08B 11.29%
2017-12-31 $0.01B $0.08B 11.65%
2017-09-30 $0.02B $0.08B 20.00%
2017-06-30 $0.01B $0.08B 19.18%
2017-03-31 $0.01B $0.07B 18.18%
2016-12-31 $0.01B $0.07B 16.84%
2016-09-30 $0.01B $0.07B 16.78%
2016-06-30 $0.01B $0.07B 17.08%
2016-03-31 $0.01B $0.07B 17.27%
2015-12-31 $0.01B $0.07B 17.78%
2015-09-30 $0.01B $0.07B 18.11%
2015-06-30 $0.01B $0.07B 18.39%
2015-03-31 $0.01B $0.06B 18.60%
2014-12-31 $0.01B $0.07B 18.68%
2014-09-30 $0.01B $0.06B 18.97%
2014-06-30 $0.01B $0.07B 19.51%
2014-03-31 $0.01B $0.06B 20.51%
2013-12-31 $0.01B $0.06B 21.62%
2013-09-30 $0.01B $0.06B 20.75%
2013-06-30 $0.01B $0.05B 21.57%
2013-03-31 $0.01B $0.05B 20.30%
2012-12-31 $0.01B $0.05B 20.94%
2012-09-30 $0.01B $0.05B 22.10%
2012-06-30 $0.01B $0.05B 20.93%
2012-03-31 $0.01B $0.05B 21.69%
2011-12-31 $0.01B $0.04B 17.61%
2011-09-30 $0.01B $0.04B 17.95%
2011-06-30 $0.01B $0.04B 17.95%
2011-03-31 $0.01B $0.04B 15.48%
2010-12-31 $0.01B $0.04B 17.95%
2010-09-30 $0.01B $0.04B 17.95%
2010-06-30 $0.01B $0.04B 18.30%
2010-03-31 $0.01B $0.04B 21.33%
2009-12-31 $0.01B $0.04B 21.92%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.185B $0.041B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $235.365B 28.30
Boston Scientific (BSX) United States $147.057B 36.81
Stryker (SYK) United States $145.454B 30.41
EssilorLuxottica (ESLOY) France $130.907B 0.00
Medtronic (MDT) Ireland $112.941B 16.01
Lonza Group Ag (LZAGY) Switzerland $50.659B 0.00
Haleon (HLN) United Kingdom $49.106B 27.97
ResMed (RMD) United States $36.856B 27.68
Agilent Technologies (A) United States $34.008B 22.17
GE HealthCare Technologies (GEHC) United States $33.609B 15.96
Terumo (TRUMY) Japan $26.946B 35.00
Koninklijke Philips (PHG) Netherlands $22.201B 15.96
Insulet (PODD) United States $21.270B 83.49
Zimmer Biomet Holdings (ZBH) United States $18.645B 11.98
Baxter (BAX) United States $16.114B 12.03
Smith & Nephew SNATS (SNN) United Kingdom $13.196B 0.00
Sunny Optical Technology (SNPTF) China $9.076B 0.00
Demant (WILYY) Denmark $8.854B 0.00
Bio-Rad Laboratories (BIO) United States $6.264B 21.80
Lantheus Holdings (LNTH) United States $5.587B 14.09
Prestige Consumer Healthcare (PBH) United States $4.206B 18.79
Perrigo (PRGO) Ireland $3.763B 9.54
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.435B 15.65
ICU Medical (ICUI) United States $3.309B 24.40
Envista Holdings (NVST) United States $3.259B 27.08
GN Store Nord (GNNDY) Denmark $2.362B 19.57
QuidelOrtho (QDEL) United States $2.094B 14.40
LeMaitre Vascular (LMAT) United States $1.878B 41.99
AtriCure (ATRC) United States $1.635B 0.00
Acuren (TIC) United States $1.305B 0.00
Neogen (NEOG) United States $1.238B 15.85
AdaptHealth (AHCO) United States $1.181B 11.99
BioLife Solutions (BLFS) United States $1.128B 0.00
Green Thumb Industries (GTBIF) United States $1.075B 24.19
Kestra Medical Technologies (KMTS) United States $1.001B 0.00
Phibro Animal Health (PAHC) United States $0.989B 12.64
InMode (INMD) Israel $0.903B 9.10
Evolus (EOLS) United States $0.660B 0.00
CeriBell (CBLL) United States $0.642B 0.00
Owens & Minor (OMI) United States $0.606B 5.03
Capricor Therapeutics (CAPR) United States $0.600B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.581B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Valneva SE (VALN) France $0.534B 0.00
Tilray Brands (TLRY) Canada $0.429B 0.00
Surmodics (SRDX) United States $0.415B 0.00
VAREX IMAGING (VREX) United States $0.359B 13.21
SNDL (SNDL) Canada $0.349B 0.00
Aurora Cannabis (ACB) Canada $0.340B 60.40
Canopy Growth (CGC) Canada $0.289B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.283B 0.00
Cerus (CERS) United States $0.271B 0.00
Sanuwave Health (SNWV) United States $0.268B 0.00
Viemed Healthcare (VMD) United States $0.267B 22.50
ZimVie (ZIMV) United States $0.265B 12.06
Cresco Labs (CRLBF) United States $0.261B 0.00
Quanterix (QTRX) United States $0.259B 0.00
Sanara MedTech (SMTI) United States $0.257B 0.00
Brainsway (BWAY) Israel $0.222B 58.65
Biote (BTMD) United States $0.220B 6.18
OraSure Technologies (OSUR) United States $0.218B 0.00
Omeros (OMER) United States $0.212B 0.00
TriSalus Life Sciences (TLSI) United States $0.199B 0.00
Organigram Global (OGI) Canada $0.197B 0.00
High Tide (HITI) Canada $0.190B 0.00
Verano Holdings (VRNOF) United States $0.183B 0.00
Exagen (XGN) United States $0.155B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.130B 16.05
Jin Medical (ZJYL) China $0.108B 0.00
MacroGenics (MGNX) United States $0.108B 0.00
Veru (VERU) United States $0.099B 0.00
Quipt Home Medical (QIPT) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
Fonar (FONR) United States $0.090B 11.61
TerrAscend (TSNDF) Canada $0.078B 0.00
Agape ATP (ATPC) $0.078B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Apyx Medical (APYX) United States $0.067B 0.00
Zynex (ZYXI) United States $0.062B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.057B 0.00
Modular Medical (MODD) United States $0.047B 0.00
Nephros (NEPH) United States $0.040B 54.21
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
Cellectar Biosciences (CLRB) United States $0.020B 0.00
Safety Shot (SHOT) United States $0.019B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
INLIF (INLF) $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.012B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00